To complement the knowledge on the anti-inflammatory activity of methyl and isopropyl N-methylanthranilates, two natural products with panacea-like properties, we investigated their effects on thioglycolate-elicited macrophages by evaluating macrophage ability to metabolize MTT, macrophage membrane function, and macrophage myeloperoxidase and phagocytic activities. Moreover, two additional aspects of the inflammatory response of these compounds, their inhibitory activity on xanthine oxidase and catalase, were studied. It was found that these two compounds regulate elicited macrophage functions, most probably by interfering with the function of cell membranes and changing the reducing cellular capacity or enzyme activity of macrophages. Nonetheless, no significant inhibitory action either towards xanthine oxidase or catalase was found, suggesting that the inhibition of these enzymes is not involved in the anti-inflammatory mode of action of these two esters.

Download full-text PDF

Source
http://dx.doi.org/10.1002/cbdv.202100724DOI Listing

Publication Analysis

Top Keywords

methyl isopropyl
8
isopropyl n-methylanthranilates
8
mode action
8
xanthine oxidase
8
oxidase catalase
8
macrophage
5
n-methylanthranilates affect
4
affect primary
4
primary macrophage
4
macrophage function
4

Similar Publications

In recent decades, Alzheimer's disease (AD) has garnered significant attention due to its rapid global prevalence. The cholinergic hypothesis posits that the degradation of acetylcholine by acetylcholinesterase (AChE) contributes to AD development. Despite existing anti-AChE drugs, their adverse side effects necessitate new agents.

View Article and Find Full Text PDF

Multidrug-resistant (MDR) remains a significant global health threat. This study aimed to explore the potential of essential oil components as novel inhibitors of the MDR efflux pumps AcrAB and AcrD. isolates were characterized for serotype, antibiotic resistance, and efflux pump activity.

View Article and Find Full Text PDF

Forensic Aspects of Designer LSD Analogs Identification by GC-MS (EI) and UV Spectroscopy.

Molecules

December 2024

Department of Forensic Medicine, Wroclaw Medical University, 4 J. Mikulicza-Radeckiego Street, 50-345 Wroclaw, Poland.

Lysergic acid diethylamide (LSD) analogs, often referred to as new psychoactive substances, are synthesized to mimic controlled substances while evading drug regulations. This study emphasizes the challenges of identifying these compounds, particularly their isomeric forms. Gas chromatography-mass spectrometry (GC-MS) and UV spectroscopy were employed to analyze 13 LSD analogs.

View Article and Find Full Text PDF

Effects of silica nanoparticle addition and PDMS coating on membrane performance and stability in the extraction of aromatic amines.

J Colloid Interface Sci

December 2024

Materials & Process Engineering (IMAP), UCLouvain, Place Sainte Barbe 2, B-1348 Louvain-la-Neuve, Belgium; Research & Innovation Centre for Process Engineering (ReCIPE), Place Sainte Barbe 2, bte L5.02.02, B-1348 Louvain-la-Neuve, Belgium.

This study investigates novel strategies to improve membrane performance and stability in the extraction of aromatic amines for chiral amine production. The effects of silica nanoparticle addition and polydimethylsiloxane (PDMS) coating were explored, with a focus on the selective extraction of α-methylbenzylamine (MBA) and 1-methyl-3-phenylpropylamine (MPPA) from isopropyl amine (IPA). This work introduces a comparative analysis between open and tight membrane extraction (ME) systems, with and without the ionic liquid (IL) [P][N(Tf)].

View Article and Find Full Text PDF

Circumventing Imatinib resistance in CML: Novel Telmisartan-based cell death modulators with improved activity and stability.

Eur J Med Chem

November 2024

Department of Internal Medicine V, Hematology and Oncology, Tyrolean Cancer Research Institute (TKFI), Comprehensive Cancer Center Innsbruck (CCCI), Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Electronic address:

Drug resistance presents a significant challenge in cancer therapy, which has led to intensive research in resistance mechanisms and new therapeutic strategies. In chronic myeloid leukemia (CML), the introduction of Imatinib, the first tyrosine kinase inhibitor (TKI), drastically changed the outcome for patients. However, complete remission still cannot be achieved in a large number of patients in the long term.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!